Cencora, INC Form 4 insider transactions

NYSE
Cencora, Inc. Executive Vice President Silvana Battaglia acquired additional common stock shares through an employee stock purchase plan.
NYSE
Cencora, Inc. Director Lori Ryerkerk was granted 516 restricted stock units, which are set to vest on July 1, 2026.
NYSE
Cencora's Executive Chairman, Steven H. Collis, executed a pre-arranged transaction on June 24, 2025, involving the exercise of stock options and the subsequent sale of common stock.
NYSE
Cencora Executive Vice President Silvana Battaglia sold 4,077 shares of common stock for approximately $297.41 per share under a Rule 10b5-1 trading plan.
NYSE
Cencora's President and CEO, Robert P. Mauch, exercised stock options and subsequently sold a portion of his common stock holdings on June 18, 2025, under a pre-established Rule 10b5-1 trading plan.
NYSE
Lazarus Krikorian, SVP & Chief Accounting Officer of Cencora, Inc., reported the sale of 3,000 shares of company common stock for approximately $866,816 on May 29, 2025.
NYSE
Cencora's CEO, Robert Mauch, exercised stock options and sold a portion of the acquired shares on May 19, 2025, according to a recent SEC filing.
NYSE
Steven Collis, Executive Chairman of Cencora, exercised stock options and sold shares under a pre-arranged Rule 10b5-1 trading plan.
NYSE
Director Lon R. Greenberg sold 3,000 shares of Cencora, Inc. common stock at a price of $279.05 on May 14, 2025.
NYSE
Director Dennis M. Nally acquired 121 shares of Cencora, Inc. common stock on May 1, 2025, in lieu of a $35,000 cash retainer.
NYSE
Director Werner Baumann acquired 125 shares of Cencora, Inc. through restricted stock units (RSUs) in lieu of a quarterly cash retainer.
NYSE
Director Lauren M. Tyler acquired 104 shares of Cencora, Inc. common stock on May 1, 2025, in lieu of a $30,000 quarterly cash retainer.
NYSE
Cencora's CFO, James F. Cleary, reported a transfer of 35,000 common stock shares to his spouse as part of a divorce settlement agreement on April 23, 2025.
NYSE
Steven Collis, Executive Chairman of Cencora, exercised stock options and sold shares under a pre-arranged Rule 10b5-1 trading plan.
NYSE
Cencora's President and CEO, Robert P. Mauch, exercised stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.
NYSE
Steven Collis, Executive Chairman of Cencora, Inc., exercised stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.
NYSE
Executive Vice President Elizabeth S. Campbell reported the sale of Cencora, Inc. common stock on March 24, 2025, under a pre-arranged Rule 10b5-1 trading plan.
NYSE
Cencora's CEO, Robert P. Mauch, exercised stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.
NYSE
Lazarus Krikorian, SVP & Chief Accounting Officer of Cencora Inc., reported selling 2,000 shares of common stock at $260.06 per share on March 10, 2025.
NYSE
Director Redonda Miller reports acquiring 789 shares of Cencora common stock and disposing of 3,194 shares.
NYSE
Director Lorence H. Kim reports acquisition of restricted stock units and updates to beneficial ownership of Cencora, Inc. common stock.
NYSE
Director Werner Baumann reports acquisition of 789 shares and disposal of 2,771 shares of Cencora, Inc. common stock on March 6, 2025.
NYSE
Director Frank Clyburn receives restricted stock units in Cencora, Inc.
NYSE
Director Lon R. Greenberg reports acquiring 789 shares of Cencora, Inc. through restricted stock units.
NYSE
Director Dennis M. Nally reports acquiring 789 shares of Cencora, Inc. common stock on March 6, 2025, bringing his total holdings to 13,130 shares.
NYSE
Director Lauren M. Tyler reports acquiring 789 shares of Cencora Inc. common stock and disposing of 2,771 shares on March 6, 2025.
NYSE
Director Dermot Mark Durcan reports acquisition of 986 shares of Cencora, Inc. common stock through a grant of restricted stock units.
NYSE
Cencora's CEO, Robert P. Mauch, exercised stock options and sold shares of common stock on March 3, 2025, under a pre-arranged Rule 10b5-1 trading plan.
NYSE
Steven H. Collis, Executive Chairman of Cencora, Inc., reports the sale and acquisition of common stock and the exercise of stock options on February 27, 2025.
NYSE
Silvana Battaglia, Executive Vice President of Cencora, Inc., reported the sale of 5,000 shares of common stock on February 21, 2025.